Metraipolis › archive › dc_b84792b28e0e

Optimising Therapeutic Intervals for Anti-TNF Biologics in Rheumatoid Arthritis: A Retrospective Real-World Study — Europe PMC PMID:42195279

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42195279
DOI
10.3390/life16050723
License (as archived)
solo-consultazione
Archived
2026-11-03T07:30:19.433Z
SHA-256 of the archived text
47993b9383917c068a6a433822aff0b759a4d86ce0ea4fe8ca191690cc7e0841
Stable URL of this page
https://metraipolis.com/documento/dc_b84792b28e0e

How to cite

Optimising Therapeutic Intervals for Anti-TNF Biologics in Rheumatoid Arthritis: A Retrospective Real-World Study — Europe PMC PMID:42195279 — Europe PMC (en), https://europepmc.org/article/MED/42195279 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b84792b28e0e (Metraipolis archive dc_b84792b28e0e, sha256 47993b9383917c068a6a433822aff0b759a4d86ce0ea4fe8ca191690cc7e0841)
BibTeX
@misc{dcb84792b28e0e,
  title = {Optimising Therapeutic Intervals for Anti-TNF Biologics in Rheumatoid Arthritis: A Retrospective Real-World Study — Europe PMC PMID:42195279},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42195279},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b84792b28e0e; sha256 47993b9383917c068a6a433822aff0b759a4d86ce0ea4fe8ca191690cc7e0841},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42195279. Agents can read the archived copy with the MCP tool read_document.